
English

Hebrew

Russian

Head of Gynecologic Oncology Department, Ichilov – Sourasky Medical Complex

Chief Physician of Gynecologic Oncology Department, Ichilov – Sourasky Medical Complex in Israel

Tel Aviv University, Professor of the Department of Obstetrics and Gynecology

University of Toronto (Canada), specialization in gynecologic oncology

Hebrew University of Jerusalem, Faculty of Medicine

American Society of Gynecologic Oncology

Canadian Society of Gynecologic Oncology

Israel Society of Obstetrics and Gynecology

Israel Society of Gynecologic Oncology
Professor Grisaru Talks about Ovarian Cancer Treatment:

“Ovarian cancer treatment consists of 2 parts.
The 1st part is surgery. One or both ovaries are removed depending on the stage of cancer at the time of diagnosis. Most often, ovarian cancer is diagnosed in advanced stages. In this case, the doctor removes not only the ovaries, but also uterus and the whole tumor that has spread beyond the ovaries into the abdominal cavity.
We strive for complete removal of the tumor from the abdominal cavity!
The 2nd part of treatment is drug therapy. This is chemotherapy commonly prescribed after surgery. Sometimes, when we suspect that complete removal of the tumor from the abdominal cavity will be difficult, we start with chemotherapy and then perform surgery.
In addition to surgery, we may perform intraperitoneal chemotherapy that involves administration of drugs into the open abdominal cavity. If tumor cells remain there, they will be destroyed.

Nowadays, we tend to avoid systemic chemotherapy that affects both cancerous and healthy cells. We prefer targeted therapy. Unlike conventional chemotherapy, targeted therapy is a biological treatment.
Cancerous cells are altered cells that differ from normal ones. The understanding of the cellular changes helps us target and destroy these cells. For instance, ovarian cancer is treated with the Avastin targeted drug also used for breast cancer treatment”.

Publications in Foreign Medical Journals:
Complete list (83):
https://www.ncbi.nlm.nih.gov/pubmed?term=grisaru%2C%20dan

Author’s Name: Dmitry Finkelstein